首页 | 官方网站   微博 | 高级检索  
     

美托洛尔治疗尿毒症患者慢性心力衰竭的疗效观察
引用本文:李珂.美托洛尔治疗尿毒症患者慢性心力衰竭的疗效观察[J].中国医药指南,2011,9(9):15-17.
作者姓名:李珂
作者单位:四川省彭山县人民医院,四川,彭山,620860
摘    要:目的观察倍他乐克在尿毒症合并慢性心力衰竭治疗中的治疗作用。方法将48例慢性心力衰竭患者随机分为两组,治疗组24例,在常规抗心力衰竭治疗基础上加用倍他乐克;对照组24例,以利尿剂、强心剂、血管紧张素转化酶抑制剂(ACEI)/(ARB)为基础的治疗。均维持治疗4个月,观察心率、BNP、超声心动图指标变化、6分钟步行试验等指标。结果治疗组心心率降低、左室射血分数增加,均优于对照组(P<0.05)。结论倍他乐克能显著改善尿毒症合并慢性心力衰竭患者的心脏功能。

关 键 词:美托洛尔  慢性心力衰竭  尿毒症

Therapeutic Effects of Metoprolol on Chronic Heart Failure in Patients with Uremia
LI Ke.Therapeutic Effects of Metoprolol on Chronic Heart Failure in Patients with Uremia[J].Guide of China Medicine,2011,9(9):15-17.
Authors:LI Ke
Affiliation:LI Ke(Pengshan People's Hospital,Pengshan 620860,China)
Abstract:Objective To explore the therapeutic effects of metoprolol on Chronic heart failure(CHF)in patients with uremia.Methods A total of 48 NYHA class II-III patients with CHF complicated by uremia were randomly divided into regularly therapy group and regularly therapy + metoprolol group.The therapeutic effects was evaluated at the end of the 4 months follow-up.Results Compared with regularly therapy group,regularly therapy + metoprolol group resulted in significant heart rate decrease and cardiac function impro...
Keywords:Metoprolol  Chronic heart failure  Uremia  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号